Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants
Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants
Not yet recruiting · NCT07112430 · Registry updated 2026-06-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Infant, Premature, Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, Obstetric Labor Complications, Obstetric Labor, Premature, Pain, Pathological Conditions, Signs and Symptoms, Premature Birth, Signs and Symptoms, Urogenital Diseases, agnosia, eye disorder, nervous system disorder, perceptual disorders, pregnancy disorder, retinal disorder, retinopathy of prematurity | Not yet recruiting | Phase 1 / Phase 2 | 2026-06-30 | NCT07112430 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Institutes of Health Research (CIHR) | 339 |
| Dalhousie University | 49 |
| IWK Health Centre | 30 |
| Marsha Campbell-Yeo | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| IWK Health | Halifax | Canada | 4 |